KLOW Blend

Gut-healing peptide blend combining KPV, LL-37, BPC-157 and Larazotide in one vial. Targets intestinal permeability, chronic gut inflammation and microbiome balance.

Route: SubQShelf life once mixed: ~30 daysCategory: Healing & Recovery

What KLOW Blend is

KLOW Blend is a research peptide formulation containing KPV, LL-37, BPC-157, and Larazotide, designed to influence aspects of gastrointestinal health. KPV, a fragment of alpha-melanocyte-stimulating hormone, is understood to exert anti-inflammatory effects by modulating pathways such as NF-κB, which can impact cytokine production. LL-37 is a cathelicidin-derived antimicrobial peptide involved in innate immunity, contributing to pathogen defense and immune modulation, potentially through interactions with specific cell surface receptors or direct microbial membrane disruption. BPC-157 is recognized for its cytoprotective properties, promoting angiogenesis and tissue regeneration through influencing growth factors and nitric oxide pathways. Larazotide acetate acts as a zonulin antagonist, aiming to prevent the disruption of tight junctions in the intestinal lining. The combined activity of these peptides targets multiple aspects of intestinal integrity, inflammatory response, and microbial balance, though the precise pharmacokinetics and overall half-life of the blend in vivo would be influenced by the individual properties of each constituent.

In research settings, the application of KLOW Blend is often explored over a period of weeks to months, reflecting the time potentially required for significant tissue regeneration and modulation of chronic inflammatory processes within the gut. Observations on improvements in markers related to intestinal permeability or inflammation may become evident within this timeframe. While KLOW Blend is itself a complex formulation, researchers may consider its use alongside dietary interventions, prebiotics, or probiotics in studies investigating comprehensive gut health approaches. Typical administration methods in research involve subcutaneous injection of the specified blend units. It is important to emphasize that KLOW Blend is intended strictly for research purposes and is not approved for human therapeutic use; this information does not constitute medical advice.

Commonly reported effects

Gut lining repair
Reduced GI inflammation
Improved digestion
Immune modulation

Reported side effects & considerations

Mild bloating first week
Rare injection site irritation

Storage & handling

LYOPHILIZED (unopened): store at 2-8°C (fridge) or -20°C (freezer) long-term. Protect from light.

AFTER RECONSTITUTION: refrigerate 2-8°C. Do NOT freeze. Discard after 30 days OR if the solution becomes cloudy, discolored, or contains particulates.

What people track

Because individual responses vary so much, the useful thing is your own record: what you logged and when, how much is left in the vial, and how your chosen metrics move over the weeks. Peptide Wizard keeps all of that in one place, alongside a 3D reference vial for KLOW Blend.

FAQ

What is KLOW Blend?

Gut-healing peptide blend combining KPV, LL-37, BPC-157 and Larazotide in one vial. Targets intestinal permeability, chronic gut inflammation and microbiome balance.

What do people commonly report with KLOW Blend?

Commonly reported effects include gut lining repair, reduced gi inflammation, improved digestion, immune modulation.

How should KLOW Blend be stored?

LYOPHILIZED (unopened): store at 2-8°C (fridge) or -20°C (freezer) long-term. Protect from light.

How do I keep track of KLOW Blend in my research log?

Peptide Wizard lets you record each entry, keep a vial ledger so you know what's left, and chart your own metrics over time. It is a logbook and reference only — it does not calculate or recommend doses.